搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Haloquadratum walsbyi UPF0447 protein HQ1094A (HQ1094A), partial CSB-YP615151HAAE
CSB-EP615151HAAE
CSB-BP615151HAAE
CSB-MP615151HAAE
CSB-EP615151HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP615152HAAE
CSB-EP615152HAAE
CSB-BP615152HAAE
CSB-MP615152HAAE
CSB-EP615152HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Urease subunit gamma (ureA) CSB-YP615153HAAE
CSB-EP615153HAAE
CSB-BP615153HAAE
CSB-MP615153HAAE
CSB-EP615153HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi DNA polymerase II large subunit (polC), partial CSB-YP615154HAAE
CSB-EP615154HAAE
CSB-BP615154HAAE
CSB-MP615154HAAE
CSB-EP615154HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Translation initiation factor 1A 1 (eif1a1) CSB-YP615155HAAE
CSB-EP615155HAAE
CSB-BP615155HAAE
CSB-MP615155HAAE
CSB-EP615155HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Histidinol-phosphate aminotransferase (hisC) CSB-YP615156HAAE
CSB-EP615156HAAE
CSB-BP615156HAAE
CSB-MP615156HAAE
CSB-EP615156HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi UPF0290 protein HQ3230A (HQ3230A), partial CSB-YP615157HAAE1
CSB-EP615157HAAE1
CSB-BP615157HAAE1
CSB-MP615157HAAE1
CSB-EP615157HAAE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Probable glucose-6-phosphate isomerase (pgi) CSB-YP615158HAAE
CSB-EP615158HAAE
CSB-BP615158HAAE
CSB-MP615158HAAE
CSB-EP615158HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi 30S ribosomal protein S4P (rps4p) CSB-YP615159HAAE
CSB-EP615159HAAE
CSB-BP615159HAAE
CSB-MP615159HAAE
CSB-EP615159HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi 30S ribosomal protein S11P (rps11p) CSB-YP615160HAAE
CSB-EP615160HAAE
CSB-BP615160HAAE
CSB-MP615160HAAE
CSB-EP615160HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi 50S ribosomal protein L3P (rpl3p) CSB-YP615161HAAE
CSB-EP615161HAAE
CSB-BP615161HAAE
CSB-MP615161HAAE
CSB-EP615161HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi 50S ribosomal protein L2P (rpl2p) CSB-YP615162HAAE
CSB-EP615162HAAE
CSB-BP615162HAAE
CSB-MP615162HAAE
CSB-EP615162HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi 50S ribosomal protein L14P (rpl14p) CSB-YP615163HAAE
CSB-EP615163HAAE
CSB-BP615163HAAE
CSB-MP615163HAAE
CSB-EP615163HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Proteasome subunit beta (psmB) CSB-YP615164HAAE
CSB-EP615164HAAE
CSB-BP615164HAAE
CSB-MP615164HAAE
CSB-EP615164HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi UPF0753 protein HQ2622A (HQ2622A), partial CSB-YP615165HAAE
CSB-EP615165HAAE
CSB-BP615165HAAE
CSB-MP615165HAAE
CSB-EP615165HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Threonine--tRNA ligase (thrS), partial CSB-YP615166HAAE
CSB-EP615166HAAE
CSB-BP615166HAAE
CSB-MP615166HAAE
CSB-EP615166HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Transcription factor E (tfe) CSB-YP615167HAAE
CSB-EP615167HAAE
CSB-BP615167HAAE
CSB-MP615167HAAE
CSB-EP615167HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi HGPRTase-like protein 2 (HQ2050A) CSB-YP615168HAAE
CSB-EP615168HAAE
CSB-BP615168HAAE
CSB-MP615168HAAE
CSB-EP615168HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Protein pelota homolog (pelA) CSB-YP615169HAAE
CSB-EP615169HAAE
CSB-BP615169HAAE
CSB-MP615169HAAE
CSB-EP615169HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haloquadratum walsbyi Translation initiation factor 1A 2 (eif1a2) CSB-YP615170HAAE
CSB-EP615170HAAE
CSB-BP615170HAAE
CSB-MP615170HAAE
CSB-EP615170HAAE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>